Dr. Martens plc (LON:DOCS) Insider Lynne Weedall Buys 4,000 Shares of Stock

Posted by on Jun 6th, 2023

Dr. Martens plc (LON:DOCS – Get Rating) insider Lynne Weedall acquired 4,000 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The shares were bought at an average price of GBX 136 ($1.69) per share, for a total transaction of £5,440 ($6,762.80).

Dr. Martens Stock Performance

Shares of LON DOCS opened at GBX 134.10 ($1.67) on Tuesday. The stock has a market cap of £1.34 billion, a price-to-earnings ratio of 745.00, a P/E/G ratio of 0.04 and a beta of 0.08. The stock’s 50-day moving average is GBX 156.69 and its 200 day moving average is GBX 169.05. The company has a current ratio of 2.39, a quick ratio of 1.13 and a debt-to-equity ratio of 125.74. Dr. Martens plc has a 1-year low of GBX 127.10 ($1.58) and a 1-year high of GBX 295.21 ($3.67).

Dr. Martens Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Tuesday, July 18th. Stockholders of record on Thursday, June 8th will be issued a GBX 4.28 ($0.05) dividend. This represents a dividend yield of 2.74%. This is a positive change from Dr. Martens’s previous dividend of $1.56. The ex-dividend date is Thursday, June 8th. Dr. Martens’s payout ratio is presently 3,333.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on DOCS shares. Royal Bank of Canada downgraded shares of Dr. Martens to a “sector perform” rating and lowered their price target for the stock from GBX 230 ($2.86) to GBX 180 ($2.24) in a report on Tuesday, May 30th. Barclays reissued an “overweight” rating and set a GBX 175 ($2.18) price objective on shares of Dr. Martens in a research note on Monday. Finally, Numis Securities reaffirmed an “add” rating and issued a GBX 180 ($2.24) price target on shares of Dr. Martens in a report on Friday, February 24th.

Dr. Martens Company Profile

(Get Rating)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name.

Read More

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.